Laboratory of Receptor and Signal Transduction, Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, Mississippi 39216-4505, USA.
Am J Physiol Renal Physiol. 2012 Dec 15;303(12):F1617-28. doi: 10.1152/ajprenal.00219.2012. Epub 2012 Oct 3.
Expression of a cytosolic cyan fluorescent fusion protein of angiotensin II (ECFP/ANG II) in proximal tubules increases blood pressure in rodents. To determine cellular signaling pathways responsible for this response, we expressed ECFP/ANG II in transport-competent mouse proximal convoluted tubule cells (mPCT) from wild-type (WT) and type 1a ANG II receptor-deficient (AT(1a)-KO) mice and measured its effects on intracellular ANG II levels, surrogates of Na/H exchanger 3 (NHE3)-dependent Na(+) absorption, as well as MAP kinases and NF-κB signaling. In WT mPCT cells, ECFP/ANG II expression doubled ANG II levels, increased NHE3 expression and membrane phospho-NHE3 proteins threefold and intracellular Na(+) concentration by 65%. These responses were associated with threefold increases in phospho-ERK 1/2 and phospho-p38 MAPK, fivefold increases in p65 subunit of NF-κB, and threefold increases in phospho-IKKα/β (Ser 176/180) proteins. These signaling responses to ECFP/ANG II were inhibited by losartan (AT(1) blocker), PD123319 (AT(2) blocker), U0126 (MEK1/MEK2 inhibitor), and RO 106-9920 (NF-κB inhibitor). In mPCT cells of AT(1a)-KO mice, ECFP/ANG II also increased the levels of NHE3, p-ERK1/2, and p65 proteins above their controls, but considerably less so than in WT cells. In WT mice, selective expression of ECFP/ANG II in vivo in proximal tubules significantly increased blood pressure and indices of sodium reabsorption, in particular levels of phosphorylated NHE3 protein in the membrane fraction and proton gradient-stimulated (22)Na(+) uptake by proximal tubules. We conclude that intracellular ANG II may induce NHE3 expression and activation in mPCTs via AT(1a)- and AT(2) receptor-mediated activation of MAP kinases ERK 1/2 and NF-κB signaling pathways.
细胞溶质青荧光融合蛋白血管紧张素 II(ECFP/ANG II)在近端肾小管中的表达会增加啮齿动物的血压。为了确定负责这种反应的细胞信号通路,我们在野生型(WT)和 1 型血管紧张素 II 受体缺陷型(AT(1a)-KO)小鼠的转运功能完备的近端曲管细胞(mPCT)中表达 ECFP/ANG II,并测量其对细胞内 ANG II 水平、Na/H 交换器 3(NHE3)依赖性 Na+吸收的替代物以及 MAP 激酶和 NF-κB 信号的影响。在 WT mPCT 细胞中,ECFP/ANG II 的表达使 ANG II 水平增加了一倍,使 NHE3 表达增加了三倍,使膜磷酸化 NHE3 蛋白增加了三倍,并使细胞内 Na+浓度增加了 65%。这些反应与 ERK 1/2 和磷酸化 p38 MAPK 的三倍增加、NF-κB 的 p65 亚基的五倍增加以及磷酸化 IKKα/β(Ser 176/180)蛋白的三倍增加有关。这些对 ECFP/ANG II 的信号反应被 losartan(AT(1) 阻断剂)、PD123319(AT(2) 阻断剂)、U0126(MEK1/MEK2 抑制剂)和 RO 106-9920(NF-κB 抑制剂)抑制。在 AT(1a)-KO 小鼠的 mPCT 细胞中,ECFP/ANG II 也使 NHE3、磷酸化 ERK1/2 和 p65 蛋白的水平高于对照,但比 WT 细胞少得多。在 WT 小鼠中,ECFP/ANG II 在体内选择性表达于近端肾小管中会显著增加血压和钠重吸收的指标,特别是在膜部分的磷酸化 NHE3 蛋白水平和质子梯度刺激的(22)Na+摄取。我们得出结论,细胞内 ANG II 可能通过 AT(1a)-和 AT(2) 受体介导的 MAP 激酶 ERK 1/2 和 NF-κB 信号通路的激活,在 mPCT 中诱导 NHE3 的表达和激活。